Advertisement
Screener

Privia Health Group, Inc. (PRVA) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

2.7 / 5 stars · 31/58 Roast Me

Privia Health Group, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

Privia Health Group, Inc. (PRVA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $19.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06

  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $19.40M, a 2.90% increase year-over-year.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $21.92M, a 23.22% increase year-over-year.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $18.98M, a 25.63% increase year-over-year.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $18.85M, a 30.98% increase year-over-year.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $71.07M, a 25.38% increase from fiscal 2024.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $56.68M, a 52.78% increase from fiscal 2023.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $37.10M, a 44.92% decline from fiscal 2022.
  • Privia Health Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $67.36M, a 73.43% decline from fiscal 2021.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2026-06-30$19.40M
10-Q · filed 2026-08-06
$41.32M
derived: sum of 2 quarters · filed 2026-08-06
2026-03-31$21.92M
10-Q · filed 2026-08-06
2025-12-31$71.07M
10-K · filed 2026-02-27
2025-09-30$18.98M
10-Q · filed 2025-11-06
$37.83M
derived: sum of 2 quarters · filed 2026-08-06
$55.62M
derived: sum of 3 quarters · filed 2026-08-06
2025-06-30$18.85M
10-Q · filed 2026-08-06
$36.64M
derived: sum of 2 quarters · filed 2026-08-06
2025-03-31$17.79M
10-Q · filed 2026-08-06
2024-12-31$56.68M
10-K · filed 2026-02-27
2024-09-30$15.11M
10-Q · filed 2025-11-06
$29.50M
derived: sum of 2 quarters · filed 2025-11-06
$41.40M
derived: sum of 3 quarters · filed 2025-11-06
2024-06-30$14.39M
10-Q · filed 2025-11-06
$26.30M
derived: sum of 2 quarters · filed 2025-11-06
2024-03-31$11.90M
10-Q · filed 2025-11-06
2023-12-31$37.10M
10-K · filed 2026-02-27
2023-09-30$10.80M
10-Q · filed 2024-11-07
$20.05M
derived: sum of 2 quarters · filed 2024-11-07
$25.43M
derived: sum of 3 quarters · filed 2024-11-07
2023-06-30$9.25M
10-Q · filed 2024-11-07
$14.63M
derived: sum of 2 quarters · filed 2024-11-07
2023-03-31$5.38M
10-Q · filed 2024-11-07
2022-12-31$67.36M
10-K · filed 2025-02-27
2022-09-30$14.83M
10-Q · filed 2023-11-03
$33.30M
derived: sum of 2 quarters · filed 2023-11-03
$58.18M
derived: sum of 3 quarters · filed 2023-11-03
2022-06-30$18.47M
10-Q · filed 2023-11-03
$43.35M
derived: sum of 2 quarters · filed 2023-11-03
2022-03-31$24.88M
10-Q · filed 2023-11-03
2021-12-31$253.53M
10-K · filed 2024-02-27
2021-09-30$25.80M
10-Q · filed 2022-11-10
$228.36M
derived: sum of 2 quarters · filed 2022-11-10
$228.46M
derived: sum of 3 quarters · filed 2022-11-10
2021-06-30$202.56M
10-Q · filed 2022-11-10
$202.66M
derived: sum of 2 quarters · filed 2022-11-10
2021-03-31$101.00K
10-Q · filed 2022-11-10
2020-12-31$484.00K
10-K · filed 2023-03-01
2020-09-30$121.00K
10-Q · filed 2021-11-08
$242.00K
derived: sum of 2 quarters · filed 2021-11-08
$363.00K
derived: sum of 3 quarters · filed 2021-11-08
2020-06-30$121.00K
10-Q · filed 2021-11-08
$242.00K
derived: sum of 2 quarters · filed 2021-11-08
2020-03-31$121.00K
10-Q · filed 2021-11-08
2019-12-31$207.00K
10-K · filed 2022-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B